HIGHLIGHTS
- What: The disability rate of stroke is as high as 60%-80% , among which post-stroke hemiplegia is the main reason for the high disease burden . This study evaluated patients before and after HAMD-24 treatment. The aim of this trial protocol is to improve wheelchair, subacute, and chronic stroke motor dysfunction through MLR-DBS and to study the clinical feasibility and efficacy of MLR-DBS in humans. The study is currently being conducted at multiple centers including the Chinese People`s Liberation Army General Hospital.
- Who: Junpeng Xu from the Kyoto Tachibana University, Japan . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.